Agios Pharmaceuticals, Inc. (FRA:8AP)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,396	1,810	1,126	1,444	1,570	2,453
Market Cap Growth	-55.81%	60.74%	-22.00%	-8.03%	-36.02%	-15.67%
Enterprise Value	353	265	405	568	429	2,161
Last Close Price	24.60	31.60	20.40	25.40	29.62	35.78
PE Ratio	-	2.78	-	-	1.11	-
PS Ratio	36.58	51.35	46.40	108.35	-	-
PB Ratio	1.28	1.22	1.54	1.40	1.38	7.51
P/TBV Ratio	1.28	1.22	1.54	1.40	1.38	7.51
EV/Sales Ratio	9.17	7.51	16.70	42.61	-	-
EV/FCF Ratio	-1.00	-	-	-	-	-
Debt / Equity Ratio	0.04	0.04	0.09	0.08	0.08	0.26
Asset Turnover	0.03	0.03	0.03	0.01	-	-
Inventory Turnover	11.63	13.08	21.65	-	-	-
Quick Ratio	12.81	11.06	11.49	12.54	17.17	6.07
Current Ratio	13.82	11.90	12.27	13.30	17.79	6.75
Return on Equity (ROE)	-27.57%	57.29%	-36.83%	-19.38%	-42.15%	-63.33%
Return on Assets (ROA)	-18.71%	-20.47%	-22.49%	-18.17%	-20.65%	-24.08%
Return on Capital (ROIC)	-19.71%	-21.45%	-23.65%	-18.88%	-24.98%	-33.35%
Return on Capital Employed (ROCE)	-36.30%	-26.90%	-45.00%	-33.10%	-27.50%	-44.30%
Earnings Yield	-24.49%	35.95%	-28.29%	-15.02%	89.89%	-10.91%
FCF Yield	-25.27%	-20.89%	-23.87%	-20.38%	-23.14%	-10.16%
Buyback Yield / Dilution	-0.86%	-4.02%	-1.57%	9.36%	12.39%	-15.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.